Imbrium Therapeutics has announced the submission of an investigational new drug application (IND) to the US Food and Drug Administration for a Phase II clinical trial of sunobinop to potentially ...

IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 The IND is a comprehensive dossier of information, ...

Cellceutix Corporation has reported that the Company has filed its Investigational New Drug (IND) application for Kevetrin™, a novel anti-cancer drug, with the U.S. Food and Drug Administration (FDA).

BUSAN, South Korea--(BUSINESS WIRE)--NexThera Co., Ltd. (CEO SaeGwang Park) announced that it has submitted a Phase 1/2a Investigational New Drug (IND) application to the U.S. Food and Drug ...

Neurizon has filed an Investigational New Drug application with the US FDA for lead drug candidate NUZ-001 to treat amyotrophic lateral sclerosis. Filing marks a pivotal step in enabling start of ...

Filing marks a pivotal step in enabling start of phase 2/3 trial of NUZ-001 within the Healey ALS Platform Trial framework The FDA has 30 days to review the application, with Neurizon expecting to ...

BOSTON and LONDON, April 22, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are ...

LONDON, Dec. 06, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), the biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry ...